semaglutide
Facts
14 properties- Instance of
- type of chemical entity
- Author
- The Independent
- Subclass of
- synthetic peptide, glucagon-like peptide-1, protein
- Part of
- cagrilintide/semaglutide
- Canonical SMILES
- CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(N)Cc1cnc[nH]1)C(C)O)C(C)O)C(C)C)C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C
- Chemical formula
- C₁₈₇H₂₉₁N₄₅O₅₉
- Defined daily dose
- 0.11 mg
- Development code
- NNC 0113-0217
- Isomeric SMILES
- CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@H](CC6=CN=CN6)N
- Legal status (medicine)
- boxed warning
- Mass
- 4,111.115376892007 Da
- Medical condition treated
- type 2 diabetes, obesity
- Physically interacts with
- Glucagon like peptide 1 receptor
- OpenAlex ID
- C2909862629
- ATC code
- A10BJ06
- CAS Registry Number
- 910463-68-2
- ChEBI ID
- 167574
- ChEMBL ID
- CHEMBL3616752
- ChemSpider ID
- 34985066
- Described at URL
- bnf.nice.org.uk, www.sciencealert.com, www.independent.co.uk, gsrs.ncats.nih.gov
- DrugBank ID
- DB13928
- EC number
- 691-729-9
- ECHA Substance Infocard ID
- 100.219.541
- Google Knowledge Graph ID
- /g/11dyzd5snl
- Guide to Pharmacology Ligand ID
- 9724
Show all 26 identifiers +14
- InChIKey
- DLSWIYLPEUIQAV-CCUURXOWSA-N
- LiverTox ID
- Semaglutide
- MeSH descriptor ID
- D000099194
- MeSH tree code
- D06.472.317.680.500.751
- Probes And Drugs ID
- PD076099
- RxNorm CUI
- 1991302
- Store medisinske leksikon ID
- semaglutid
- SureChEMBL ID
- 29350607
- UK Parliament thesaurus ID
- 517986
- UNII
- 53AXN4NNHX
- UniChem compound ID
- 59720028
- WikiProjectMed ID
- Semaglutide
Medical condition treated 2
Author 1
Instance of 1
Legal status (medicine) 1
Subclass of 1
← Drug or therapy used for treatment 1
← Main subject 1
← Product or material produced 1
0 sources
Summary
semaglutide is a type of chemical entity[1]. semaglutide is a type of synthetic peptide[2], glucagon-like peptide-1[3], and protein[4].
Key Facts
- Author: The Independent[5]
- Physically interacts with: Glucagon like peptide 1 receptor[6]
- Canonical SMILES: CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(N)Cc1cnc[nH]1)C(C)O)C(C)O)C(C)C)C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C[7]
- Chemical formula: C₁₈₇H₂₉₁N₄₅O₅₉[8]
- Part of: cagrilintide/semaglutide[9]
- Isomeric SMILES: CCC@HC@@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)CNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)C@HNC(=O)CNC(=O)C@HNC(=O)C(C)(C)NC(=O)C@HNC@H[C@@H](C(=O)NC@@HC(=O)NC@@HC(=O)NC@@HC(=O)NC@@HC(=O)NC@@HC(=O)NCC(=O)NC@@HC(=">[10]
- Mass: 4111.115376892007 dalton[11]
- Medical condition treated: type 2 diabetes[12], obesity[13]
- Legal status (medicine): boxed warning[14]
- Active ingredient in: Ozempic[15], Wegovy[16], Rybelsus[17]
- Defined daily dose: 0.11 milligram[18]
- Development code: NNC 0113-0217[19]
high ≥ 0.90 · emerging ≥ 0.65 · low below — calibrated against hand-rated truth (single-source .44 · two-source .62 · production-typical .70), so a band is a measurement, not a promise. High is rare by design: it needs both a supported assertion and an evidence sentence. A confirmed or contradicted chip is a Wikidata cross-check; no chip means Wikidata has no value for that property — the ordinary case here, and it says nothing either way. A confirm-only note marks a property whose check can never disagree (Wikidata's border and capital data is not exhaustive), so silence there is a limit of the check, not of the claim.
evidence “Semaglutide was developed by Danish pharmaceutical manufacturer Novo Nordisk and branded Ozempic.” businessday.co.za · read source